---
title: "VieMed Healthcare posts March 2026 investor deck with $315M 2026 revenue guidance, $65M–$69M Adj. EBITDA"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/279323768.md"
description: "VieMed Healthcare has released its investor deck for March 2026, projecting 2026 revenue between $310M and $320M, with Adjusted EBITDA expected to be between $65M and $69M. The company reported 2025 results of $270.3M in net revenue and $61.4M in Adjusted EBITDA. They serve over 172,000 patients nationwide and have authorized a new share repurchase program for up to 5% of outstanding shares. Strategic priorities include organic expansion and leveraging AI/technology for growth."
datetime: "2026-03-16T20:53:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/279323768.md)
  - [en](https://longbridge.com/en/news/279323768.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/279323768.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/279323768.md) | [繁體中文](https://longbridge.com/zh-HK/news/279323768.md)


# VieMed Healthcare posts March 2026 investor deck with $315M 2026 revenue guidance, $65M–$69M Adj. EBITDA

**VieMed Healthcare presented an investor deck highlighting record 2025 results and 2026 guidance of $310M–$320M revenue and $65M–$69M Adjusted EBITDA.**

**Key Highlights:**

-   Reported 2025 results: $270.3M net revenue, $61.4M Adjusted EBITDA, $28.1M free cash flow and $0 net debt.
-   Provided 2026 guidance: Net revenue $310M–$320M and Adjusted EBITDA $65M–$69M; Q1 revenue flat to slightly down.
-   Operational scale: serving 172,000+ patients across all 50 states; 62% YoY PAP patient growth in 2025.
-   Board authorized new share repurchase program up to 5% of shares outstanding.
-   Strategic priorities: organic expansion, active M&A pipeline, AI/technology to drive efficiency and capital-light growth (sleep, maternal health).

Original SEC Filing: VIEMED HEALTHCARE, INC. \[ VMD \] - 8-K - Mar. 16, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### 相关股票

- [Viemed Healthcare (VMD.US)](https://longbridge.com/zh-CN/quote/VMD.US.md)

## 相关资讯与研究

- [Viemed Healthcare Highlights Growth, Diversification and 2026 Guidance at Investor Conference](https://longbridge.com/zh-CN/news/280063858.md)
- [Viemed Healthcare to Present at Sidoti's Small-Cap Virtual Investor Conference March 18-19 | VMD Stock News](https://longbridge.com/zh-CN/news/279324333.md)
- [Viemed Healthcare reports mixed Q4 results; introduces FY26 outlook](https://longbridge.com/zh-CN/news/277881209.md)
- [Viemed Healthcare's Q4 revenue rises 26%, net income up 31%](https://longbridge.com/zh-CN/news/277838287.md)
- [A Peek at Viemed Healthcare's Future Earnings](https://longbridge.com/zh-CN/news/277656999.md)